Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 6/20 | 0.54 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | PTGIR | P43119 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22632056 | 0.90 | PPARA (0.47) | PPARAPPARGCNR1CNR2PTGIR | |
| SCHEMBL17424577 | 0.83 | PPARA (0.62) | PPARAPPARGCNR1CNR2PTGIR | |
| SCHEMBL14520574 | 0.81 | PPARA (0.59) | PPARAPPARGCNR1PTGIRCYP2D6 | |
| SCHEMBL12809420 | 0.78 | PPARA (0.55) | PPARAPPARGPTGIR | |
| SCHEMBL32675259 | 0.78 | PPARA (0.55) | PPARAPPARGPTGIR | |
| SCHEMBL4452302 | 0.78 | PPARA (0.55) | PPARAPPARGPTGIR | |
| SCHEMBL13206731 | 0.77 | PPARA (0.58) | PPARAPPARGCNR1EPHX2FAAH | |
| SCHEMBL18794618 | 0.77 | PPARA (0.59) | PPARAPPARGCNR1CNR2PTGIR | |
| SCHEMBL26338269 | 0.74 | PPARA (0.56) | PPARAPPARGCNR1PTGIREPHX2 | |
| SCHEMBL20779106 | 0.73 | PPARA (0.57) | PPARAPPARGCNR1CNR2PTGIR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | THE UNIVERSITY OF AKRON | 2020-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | GSTO1, FDFT1, DGAT2 | PPARA 811/4885PPARG 981/4885CNR1 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.